(-)-Caryophyllene Oxide

(-)-Caryophyllene Oxide

SCHEMBL1532444

C=C1CCC2OC2(C)CCC2C1CC2(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 1.00
FTH1 P02794 1/20 1.00
CYP2C9 P11712 1/20 1.00
CYP2C19 P33261 1/20 1.00
CNR2 P34972 2/20 0.51
PPARA Q07869 2/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 1/20 0.47
PTPN1 P18031 1/20 0.41
HSP90AA1 P07900 1/20 0.40
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(-)-Caryophyllene Oxide SCHEMBL16489852 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL18788522 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL127077 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL24110118 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL17857878 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL24110084 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL676309 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL16769854 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL21349931 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL26189380 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041725-A1 HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS PROCTER & GAMBLE (US) 2024-02-08 US claimed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
EP-4255375-A1 HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS The Procter & Gamble Company (US) 2023-10-11 EP claimed
EP-4135537-A1 AEROSOL DELIVERY DEVICE INCLUDING A SEGREGATED SUBSTRATE R. J. Reynolds Tobacco Company (US) 2023-02-22 EP claimed
WO-2022240895-A1 METHODS TO SYNTHESIZE CYCLOPENTENES AND CYCLOPENTADIENES BY RING CONTRACTION Natural Extraction Systems, LLC (US) 2022-11-17 WO claimed
WO-2022120109-A1 HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2022-06-09 WO claimed
WO-2022120218-A1 A METHOD AND SYSTEM FOR PROVIDING A HEAT-NOT-BURN TOBACCO PRODUCT IP CONCEPTS LLC (US) 2022-06-09 WO claimed
US-20220175640-A1 HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY 2022-06-09 US claimed
US-11197810-B2 Hair care compositions comprising malodor reduction compositions THE PROCTER AND GAMBLE COMPANY (US) 2021-12-14 US claimed
US-10792384-B2 Rolled fibrous structures comprising encapsulated malodor reduction compositions THE PROCTER & GAMBLE COMPANY (US) 2020-10-06 US claimed
WO-2016049398-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049396-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160090556-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049394-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049395-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049455-A1 PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049407-A1 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160090557-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160090555-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR CYP3A4 134/4885FTH1 2525/4885CYP2C9 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.